CompaniesImprimis Pharmaceuticals

Imprimis Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (6)

Total Trials

6

As Lead Sponsor

3

As Collaborator

3

Total Enrollment

496

By Phase

PHASE4: 3PHASE3: 3

By Status

COMPLETED: 3WITHDRAWN: 2TERMINATED: 1

Clinical Trials Pipeline5 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT03640650Collaborator

Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

PHASE4Terminated

80 participants

Started: Aug 15, 2018 · Completed: Mar 16, 2021

NCT03578276Collaborator

Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen

PHASE4Completed

35 participants

Started: Jun 22, 2018 · Completed: Dec 4, 2019

NCT02106962Collaborator

Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients

PHASE4Completed

17 participants

Started: Apr 30, 2014 · Completed: Aug 31, 2014

NCT01890902Lead Sponsor

Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

PHASE3Withdrawn

Started: Aug 31, 2013

NCT00765700Lead Sponsor

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

PHASE3Completed

364 participants

Started: Sep 30, 2008 · Completed: Sep 30, 2009

View all 6 trials →

Funding History (20)

8-K

Oct 6, 2025

8-K/A

Oct 1, 2025

8-K

Sep 29, 2025

8-K

Sep 26, 2025

8-K

Sep 26, 2025

8-K

Sep 19, 2025

8-K

Sep 12, 2025

8-K

Sep 9, 2025

8-K

Sep 8, 2025

8-K

Aug 25, 2025